ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-histidine
C26H27N3O6
477.5 g/mol
Pharmaceutical Intermediate

Fmoc-His(Boc)-OH

CAS81379-52-4
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Fmoc-His(Boc)-OH is a protected amino acid derivative widely employed in solid-phase peptide synthesis. Its dual protecting groups—Fmoc on the alpha-amino group and Boc on the imidazole side chain—enable sequential, selective deprotection during peptide chain assembly.

Building block for peptide synthesisIntermediate for pharmaceutical manufacturing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-His(Boc)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ApplicationSame Use

N-Boc-L-tert-Leucine

CAS62965-35-9

pharmaceutical intermediate

ReferenceSame Category

Diethyl chlorophosphate

CAS814-49-3

pharmaceutical intermediate

ReferenceSame Category

N-(Diphenylmethylene)glycine benzyl ester

CAS81477-91-0

pharmaceutical intermediate

ReferenceSame Category

N-(diphenylmethylene)glycine tert-butyl ester

CAS81477-94-3

pharmaceutical intermediate

ReferenceSame Category

[3S-(1Z,3a,5b)]-[2-[3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethyl]diphenylphosphineoxide

CAS81522-68-1

pharmaceutical intermediate

Referencesame scaffold

Fmoc-His-Aib-OH

CAS1446013-07-5

pharmaceutical intermediate

Referencesame scaffold

Semaglutide impurity 104

CAS2171211-18-8

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]imidazol-4-yl]propanoic acid

InChIKey

ZRHPMMZWDWMKPD-QFIPXVFZSA-N

SMILES

CC(C)(C)OC(=O)N1C=C(N=C1)C[C@@H](C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24

Synonyms (12)
  • 1-Boc-Nalpha-Fmoc-L-histidine
  • Fmoc-His(Boc)-OH
  • Fmoc-His(Boc)-OH.CHA
  • Fmoc-L-His(Boc)-OH
  • N-Fmoc-N'-Boc-L-histidine
  • fmoc-his(1-boc)-oh

Sourcing Fmoc-His(Boc)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→